Compare FA & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FA | STVN |
|---|---|---|
| Founded | 2003 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Business Services | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.7B |
| IPO Year | 2021 | 2021 |
| Metric | FA | STVN |
|---|---|---|
| Price | $20.19 | $18.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $15.67 | ★ $25.67 |
| AVG Volume (30 Days) | ★ 2.1M | 371.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | ★ 72.97 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,574,389,000.00 | N/A |
| Revenue This Year | $8.42 | $9.67 |
| Revenue Next Year | $7.26 | $9.99 |
| P/E Ratio | $2,053.00 | ★ $27.15 |
| Revenue Growth | ★ 83.02 | N/A |
| 52 Week Low | $8.82 | $12.89 |
| 52 Week High | $20.59 | $28.00 |
| Indicator | FA | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 80.15 | 61.94 |
| Support Level | $14.07 | $13.58 |
| Resistance Level | N/A | $19.41 |
| Average True Range (ATR) | 0.85 | 0.88 |
| MACD | 0.30 | 0.14 |
| Stochastic Oscillator | 98.81 | 99.27 |
First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.